Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 30INDUSTRY 23OTHER 7NETWORK 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gynecologic 1

Conditions

Sarcoma 18Bone Neoplasms 9Osteosarcoma 8Sarcoma, Kaposi 4Neoplasms 2Gastrointestinal Stromal Tumors 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an 1Teratoma 1Stomatitis 1Soft Tissue Neoplasms 1Risk Reduction Behavior 1Rhabdomyosarcoma 1Recurrence 1Prosthesis-Related Infections 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Muscle Tissue 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Melanoma 1Margins of Excision 1Lymphoma 1Lung Neoplasms 1Liposarcoma, Myxoid 1

Interventions

Valganciclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Acquired Immunodeficiency Syndrome × Sarcoma × Clear all
NCT03296553 2022-01-27

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

National Institute of Cancerología

Phase 2 Completed
40 enrolled 6 charts
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Immune Reconstitution Inflammatory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡